Status:
COMPLETED
Optimal Treatment Strategies for Sexually Abused Children
Lead Sponsor:
Rowan University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Child Abuse, Sexual
Eligibility:
All Genders
4-11 years
Phase:
PHASE3
Brief Summary
This study will determine the necessity of including abuse-focused interventions in the treatment of sexually abused children.
Detailed Description
Child sexual abuse is a serious public health problem that places children at high risk for developing anxiety, mood, conduct, sexual, and substance abuse disorders. It also increases their likelihood...
Eligibility Criteria
Inclusion
- Sexual abuse that has occurred within 24 months of the study. The abuse must have been substantiated by child protective services, charges must have been pressed by the prosecutor's office, or there must have been independent confirmation of abuse by a professional with recognized expertise in conducting investigative evaluations.
- Kiddie-Sads-Present and Lifetime Version (K-SADS-PL) criteria for partial or full post-traumatic stress disorder (PTSD)
- Parental consent
- Caretaker who has not abused the child
Exclusion
- Mental Retardation (IQ less than 70) or placement in special education classes
- DSM-IV criteria for Pervasive Developmental Disorders
- Psychotic disorder
- Serious medical illness that could interfere with the study
- In temporary, emergency foster care. If a child is returned home or placed in short-term foster care that is anticipated to last a minimum of 4 months, then the child is eligible for participation.
- Parent who meets DSM-IV criteria for a psychotic disorder
- Parents with serious mental health problems that result in substantial functional impairment
- Unsupervised contact with abuse perpetrator
- Receiving concurrent psychiatric treatment for the abuse. If participants previously received sexual abuse treatment that did not resolve symptomology, they are eligible to participate. In addition, children who have contact with a psychiatrist for medication monitoring purposes may be included if their medication and dosage have remained stable for at least 6 weeks prior to study start
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT00073684
Start Date
August 1 2003
End Date
July 1 2009
Last Update
May 8 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CARES Institute
Stratford, New Jersey, United States, 08084